• TechCrunch
• CrunchBase
• More
  • TechCrunch Europe
  • TechCrunch France
  • TechCrunch Japan

Ascent Biomedical Ventures

edit

Ascent Biomedical Ventures is a financial organisation which is interested in investing in seed and early-stage biomedical technology companies developing medical devices, biopharmaceuticals, healthcare services, and information technology. Their investments are concentrated in the USA.

Recent Milestones

edit

• 
  Ascent Biomedical Ventures invested in Coferon. (7/16/12)
  Posted 7/16/12 at 6:12pm via marketwire.com
• 
  Ascent Biomedical Ventures invested in Xlumena. (4/29/11)
  Posted 4/29/11 at 6:16pm via pehub.com
• 
  Ascent Biomedical Ventures invested in Cara Therapeutics. (7/21/10)
  Posted 7/21/10 at 6:59pm via fiercebiotech.com
• 
  Ascent Biomedical Ventures invested in TargAnox. (3/14/09)
  Posted 4/14/09 at 5:50am via xconomy.com
• 
  Ascent Biomedical Ventures invested in Cara Therapeutics. (11/28/06)
  Posted 4/20/10 at 4:28am via thefreelibrary.com
• 
  Ascent Biomedical Ventures invested in Cara Therapeutics. (12/21/05)
  Posted 8/30/10 at 11:43pm

Investments

Videos

Sources

1. Coferon, Inc. Announces $12 Million Series B Financing (marketwire.com) [edit]
2. Xlumena Closes $7M Series B (pehub.com) [edit]
3. Cara rounds up $15M for post-op pain drug Read more: Cara rounds up $15M for post-op pain drug (fiercebiotech.com) [edit]
4. TargAnox Launches with $5.1M Series A Round, Targeting Oxidative Stress to Treat Diseases (xconomy.com) [edit]
5. Cara Therapeutics Secures $19 Million in Series C Financing. (thefreelibrary.com) [edit]
6. EDGAR [edit]